Cargando…
Vascular disrupting agent induced aggregation of gold nanoparticles for photothermally enhanced tumor vascular disruption
Although vascular disrupting agents (VDAs) have been extensively implemented in current clinical tumor therapy, the notable adverse events caused by long-term dosing severely limit the therapeutic efficacy. To improve this therapy, we report a strategy for VDA-induced aggregation of gold nanoparticl...
Autores principales: | Hong, Sheng, Zheng, Di-Wei, Zhang, Cheng, Huang, Qian-Xiao, Cheng, Si-Xue, Zhang, Xian-Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274768/ https://www.ncbi.nlm.nih.gov/pubmed/32548273 http://dx.doi.org/10.1126/sciadv.abb0020 |
Ejemplares similares
-
Vascular disrupting agents in clinical development
por: Hinnen, P, et al.
Publicado: (2007) -
Quantifying the Evolution of Vascular Barrier Disruption in Advanced Atherosclerosis with Semipermeant Nanoparticle Contrast Agents
por: Zhang, Huiying, et al.
Publicado: (2011) -
Vascular Disrupting Agent Arsenic Trioxide Enhances Thermoradiotherapy of Solid Tumors
por: Griffin, Robert J., et al.
Publicado: (2012) -
Local application of doxorubicin- loaded Iron oxid nanoparticles and the vascular disrupting agent via the hepatic artery: chemoembolization–photothermal ablation treatment of hepatocellular carcinoma in rats
por: Yuan, Hongjun, et al.
Publicado: (2019) -
Light-initiated aggregation of gold nanoparticles for synergistic chemo-photothermal tumor therapy
por: Xia, Huawei, et al.
Publicado: (2023)